Innovation Pharmaceuticals Inc (IPIX)

[58nout]

BK I agree with you and have experienced this on a first hand basis. Access to the best care available has it's advantages. The best hospital, the best oncologists and the best surgeons all increase ones life expectancy.

My take on Keytruda is that classifying it as an immunotherapy infers that one escapes the dreadful side-effects of chemotherapy. This is very far from the truth. It's not a fun ride by any means.

This is what makes the case for Kevetrin so damn compelling. If K can increase life expectancy without the side-effects, then we have something really different and worth celebrating.

It's why I'm invested here.

GO CTIX - stay the course